Written by Christina Aungst, PharmD | Reviewed by Amy B. Gragnolati, PharmD, BCPS Published on February 11, 2022 Key takeaways: In January 2022, the FDA approved daridorexant (Quviviq) to treat insomnia in adults. It’s expected to be available in May 2022. Daridorexant is an oral tablet that you take about 30 minutes before bed. You...
(HealthDay)—Daridorexant (50 mg) improves both nighttime symptoms and daytime functioning in people with insomnia disorder, according to a study published in the Feb. 1 issue of The Lancet Neurology. Emmanuel Mignot, M.D., from the Stanford Center for Sleep Research and Medicine in Palo Alto, California, and colleagues conducted two phase 3 randomized controlled trials at 156...
